Sedatives and Hypnotics Drugs: Miscellaneous Agents

Melatonin congeners like ramelteon and tasimelteon selectively bind to melatonin receptors (MT1 and MT2), mimicking melatonin's natural action in regulating sleep-wake cycles. These agents help restore normal sleep patterns in insomnia and jet lag by synchronizing circadian rhythms. Tasimelteon is also used for non-24-hour sleep-wake disorder in blind patients.

Propofol and etomidate are intravenous anesthetic agents that work primarily by potentiating GABAA receptor activity, enhancing inhibitory neurotransmission in the central nervous system. This potentiation reduces neuronal excitability, inducing rapid sedation and anesthesia suitable for induction and maintenance during procedures. Both agents carry risks of respiratory depression and hypotension.

Suvorexant promotes sleep by blocking orexin receptors, which are neurotransmitters involved in wakefulness. Unlike agents that enhance inhibitory pathways, suvorexant directly suppresses the brain's arousal system. Common side effects include daytime sleepiness, headaches, and abnormal dreams, distinguishing its mechanism from traditional sedatives and hypnotics drugs barbiturates.

Doxepin, a tricyclic antidepressant, treats insomnia by blocking histamine receptors at low doses, promoting sedation without triggering full antidepressant effects. At these lower concentrations, it increases norepinephrine levels while minimizing anticholinergic side effects like dry mouth, constipation, and urinary retention that occur at higher therapeutic doses.

Clomethiazole enhances GABAergic neurotransmission through the same mechanism as traditional barbiturates, providing sedative and anticonvulsant effects essential for managing alcohol withdrawal syndrome. Its ability to reduce neuronal excitability prevents seizures and agitation during withdrawal. However, clomethiazole carries risks of dependence and overdose, requiring careful monitoring.

Pregabalin modulates calcium channels and GABA receptors, reducing calcium influx and inhibiting excitatory neurotransmitter release in the central nervous system. This dual action decreases neuronal excitability, promoting relaxation and sedation. Dizziness is a common side effect associated with pregabalin use.

Meprobamate is an anxiolytic that modulates GABAA receptors to reduce brain activity and induce relaxation, but it is rarely used today due to safer, more effective alternatives. Newer agents like agomelatine and ritanserin use serotonin-antagonizing mechanisms and are being studied for psychiatric applications. Meprobamate carries risks of drowsiness, dizziness, and rare thrombocytopenia.